Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial

Pieter Sonneveld; Asher Chanan-Khan; Katja Weisel; Ajay K. Nooka; Tamas Masszi; Meral Beksac; Ivan Spicka; Vania Hungria; Markus Munder; Maria-Victoria Mateos; Tomer M. Mark; Mark-David Levin; Tahamtan Ahmadi; Xiang Qin; Wendy Garvin Mayo; Xue Gai; Jodi Carey; Robin Carson; Andrew Spencer

Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial

Pieter Sonneveld^*, Asher Chanan-Khan, Katja Weisel, Ajay K. Nooka, Tamas Masszi, Meral Beksac, Ivan Spicka, Vania Hungria, Markus Munder, Maria-Victoria Mateos, Tomer M. Mark, Mark-David Levin, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Andrew Spencer

^*Corresponding author for this work

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

5 Downloads (Pure)

Original language	English
Journal	Journal of Clinical Oncology
Publication status	Published - 22 Nov 2022

Access to Document

Overall Survival With Daratumumab,Final published version, 418 KBLicence: CC BY-NC-ND

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.21.02734?role=tabLicence: CC BY-NC-ND

Cite this

Sonneveld, P., Chanan-Khan, A., Weisel, K., Nooka, A. K., Masszi, T., Beksac, M., Spicka, I., Hungria, V., Munder, M., Mateos, M-V., Mark, T. M., Levin, M-D., Ahmadi, T., Qin, X., Garvin Mayo, W., Gai, X., Carey, J., Carson, R., & Spencer, A. (2022). Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial. Journal of Clinical Oncology. https://ascopubs.org/doi/pdfdirect/10.1200/JCO.21.02734?role=tab

@article{92fdf86d149d4d9a8f3c187d1795f43c,

title = "Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial",

author = "Pieter Sonneveld and Asher Chanan-Khan and Katja Weisel and Nooka, {Ajay K.} and Tamas Masszi and Meral Beksac and Ivan Spicka and Vania Hungria and Markus Munder and Maria-Victoria Mateos and Mark, {Tomer M.} and Mark-David Levin and Tahamtan Ahmadi and Xiang Qin and {Garvin Mayo}, Wendy and Xue Gai and Jodi Carey and Robin Carson and Andrew Spencer",

year = "2022",

month = nov,

day = "22",

language = "English",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

}

Sonneveld, P, Chanan-Khan, A, Weisel, K, Nooka, AK, Masszi, T, Beksac, M, Spicka, I, Hungria, V, Munder, M, Mateos, M-V, Mark, TM, Levin, M-D, Ahmadi, T, Qin, X, Garvin Mayo, W, Gai, X, Carey, J, Carson, R & Spencer, A 2022, 'Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial', Journal of Clinical Oncology. <https://ascopubs.org/doi/pdfdirect/10.1200/JCO.21.02734?role=tab>

TY - JOUR

T1 - Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial

AU - Sonneveld, Pieter

AU - Chanan-Khan, Asher

AU - Weisel, Katja

AU - Nooka, Ajay K.

AU - Masszi, Tamas

AU - Beksac, Meral

AU - Spicka, Ivan

AU - Hungria, Vania

AU - Munder, Markus

AU - Mateos, Maria-Victoria

AU - Mark, Tomer M.

AU - Levin, Mark-David

AU - Ahmadi, Tahamtan

AU - Qin, Xiang

AU - Garvin Mayo, Wendy

AU - Gai, Xue

AU - Carey, Jodi

AU - Carson, Robin

AU - Spencer, Andrew

PY - 2022/11/22

Y1 - 2022/11/22

M3 - Article

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

ER -